Clinical features and predictors of non-cardiac death in patients hospitalised for acute myocardial infarction: Insights from the Tokyo CCU network multicentre registry.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 05 2023
Historique:
received: 18 09 2022
revised: 06 02 2023
accepted: 10 02 2023
pubmed: 16 2 2023
medline: 22 3 2023
entrez: 15 2 2023
Statut: ppublish

Résumé

Patients with acute myocardial infarction (AMI) commonly have multiple comorbidities, and some die in hospitals due to causes other than cardiac complications. However, limited information is available on noncardiac death in patients hospitalised for AMI. Therefore, the present study was performed to determine the incidence, annual trend, clinical characteristics, and predictors of in-hospital non-cardiac death in patients with AMI using the Tokyo Cardiovascular Care Unit (CCU) network registry. The registry included 38,589 consecutive patients with AMI who were admitted to the CCU between 2010 and 2019. The primary endpoint was in-hospital noncardiac death. Further, predictors of cardiac and non-cardiac death were identified. The incidence of all-cause in-hospital mortality was 7.0% (n = 2700), and the proportion of mortality was 15.6% (n = 420) and 84.4% (n = 2280) for noncardiac and cardiac causes, respectively. The proportion of noncardiac deaths did not change annually over the last decade (p = 0.66). After adjusting for all variables, age, Killip classification grade, peak creatine kinase, hemoglobin, serum creatinine, and C-reactive protein were common predictors of cardiac and non-cardiac deaths. Indicators of malnutrition, such as lower body mass index (kg/m The incidence of in-hospital noncardiac death was significant in patients with AMI, accounting for 15.6% of all in-hospital mortalities. Thus, prevention and management of non-cardiac complications are vital to improve acute-phase outcomes, especially those with predictors of non-cardiac death.

Sections du résumé

BACKGROUND
Patients with acute myocardial infarction (AMI) commonly have multiple comorbidities, and some die in hospitals due to causes other than cardiac complications. However, limited information is available on noncardiac death in patients hospitalised for AMI. Therefore, the present study was performed to determine the incidence, annual trend, clinical characteristics, and predictors of in-hospital non-cardiac death in patients with AMI using the Tokyo Cardiovascular Care Unit (CCU) network registry.
METHODS
The registry included 38,589 consecutive patients with AMI who were admitted to the CCU between 2010 and 2019. The primary endpoint was in-hospital noncardiac death. Further, predictors of cardiac and non-cardiac death were identified.
RESULTS
The incidence of all-cause in-hospital mortality was 7.0% (n = 2700), and the proportion of mortality was 15.6% (n = 420) and 84.4% (n = 2280) for noncardiac and cardiac causes, respectively. The proportion of noncardiac deaths did not change annually over the last decade (p = 0.66). After adjusting for all variables, age, Killip classification grade, peak creatine kinase, hemoglobin, serum creatinine, and C-reactive protein were common predictors of cardiac and non-cardiac deaths. Indicators of malnutrition, such as lower body mass index (kg/m
CONCLUSIONS
The incidence of in-hospital noncardiac death was significant in patients with AMI, accounting for 15.6% of all in-hospital mortalities. Thus, prevention and management of non-cardiac complications are vital to improve acute-phase outcomes, especially those with predictors of non-cardiac death.

Identifiants

pubmed: 36791966
pii: S0167-5273(23)00238-3
doi: 10.1016/j.ijcard.2023.02.022
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None declared.

Auteurs

Kohei Wakabayashi (K)

Tokyo CCU Network Scientific Committee, Tokyo, Japan; Division of Cardiology, Cardiovascular Center, Showa University Koto-Toyosu Hospital, Tokyo, Japan. Electronic address: koheiw@med.showa-u.ac.jp.

Satoshi Higuchi (S)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Hideki Miyachi (H)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Shun Minatsuki (S)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Ryosuke Ito (R)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Seita Kondo (S)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Katsumi Miyauchi (K)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Masao Yamasaki (M)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Hiroyuki Tanaka (H)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Jun Yamashita (J)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Mikio Kishi (M)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Kaito Abe (K)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Takaaki Mase (T)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Kazuyuki Yahagi (K)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Taku Asano (T)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Mike Saji (M)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Hiroshi Iwata (H)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Yuya Mitsuhashi (Y)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Ken Nagao (K)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Takeshi Yamamoto (T)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Toshiro Shinke (T)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Morimasa Takayama (M)

Tokyo CCU Network Scientific Committee, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH